Ken Webert is currently working at Intercept Pharmaceuticals as the Associate Director Key Accounts focusing on rare diseases. Prior to their current role, Ken held positions at UCB, Regeneron Pharmaceuticals, Amgen, and several other companies where Ken was involved in sales, marketing, and strategic partnerships within the healthcare industry. Ken has a Bachelor of Science in Pharmacy from Washington State University.
January, 2023 - present